Appoints Indranil Mukherjee as Chief Executive Officer, Asia Pacific and India to drive growth across key markets and advance the company's next phase of strategic expansion New Delhi, 1 June 2026: Poly Medicure Ltd. (NSE: POLYMED | BSE: 531768), India's leading medical device company
“Poised for Takeoff: MedTech in India” report launched at the national policy platform attended by over 450 delegates and 70+ eminent speakers from government, industry, research institutions, and healthcare ecosystems The 3rd Edition of MedTech Policy Mahotsav 2026, organized by Global MedTech Advocacy & Advisory Forum
Poly Medicure Ltd., one of India’s leading medical device manufacturers, has taken a decisive step in strengthening its global footprint by acquiring a 90% stake in the Netherlands-based PendraCare Group for ₹188.5 crore (€18.3 million). The acquisition, signed through a share purchase agreement with Wellinq
Quarterly and FY 25 Consolidated Revenue growth of 17% and 21% respectively on a YoY basis FY 25 Consolidated EBITDA growth of 27% on a YoY basis, Q4 Core EBITDA margin 27.1% Consolidated Quarterly and yearly PAT Growth of 34% and 31% respectively on a YoY basis;
Himanshu Baid, MD, Poly Medicure Ltd., has been reappointed as Chairman to serve on the National Medical Technology Council of the Confederation of Indian Industry (CII). This reappointment underscores his exemplary leadership and unwavering commitment to driving innovation and growth in the healthcare industry. The National
